Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 61

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 61
---
 of common stock will
be increased as a result of the fewer shares of common stock outstanding. The Reverse Stock Split will be reflected retroactively in our
consolidated financial statements.

<div align='center'>The Board of Directors recommends a vote “FOR” the approval of the Reverse Stock Split. The Board of Directors retains the discretion to abandon, and not implement, the aforementioned amendments at any time before they become effective.

34

PROPOSAL 4</div>

RATIFICATION OF THE SELECTION OF RBSM LLP AS OUR INDEPENDENT AUDITOR FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024

Proposal: The Board of Directors is asking
that you vote to ratify the Board’s selection of RBSM LLP (“RBSM”) as our independent registered public accounting firm
for fiscal year 2025.

During the year ended
December 31, 2024, and 2023, we engaged RBSM LLP as our independent registered public accounting firm. For the years ended December 31,
2024, and 2023, we incurred fees, as discussed below:

|               |     | Fiscal Year Ended 
 December 31,      |    2024 |     |   |    2023 |
|:--------------|:----|:------------------|--------:|:----|:--|--------:|
| Audit         
 Fees(1)       |     | $                 | 163,069 |     | $ | 182,000 |
| Audit-Related 
 Fees(2)       |     |                   | 135,000 |     |   |  65,000 |
| Tax           
 Fees          |     |                   |       - |     |   |       - |
| All           
 Other Fees    |     |                   |       - |     |   |       - |
| Total         |     | $                 | 298,069 |     | $ | 247,000 |

| (1) | Audit fees consist of fees                                                                                                              
 relating to the audit of the Company’s annual consolidated financial statements and reviews of interim condensed consolidated financial 
 statements.                                                                                                                             |

| (2) | Audit-related fees consisted                                                                                                   
 of reviews of the Company’s registration statements, consents, and the completion of comfort letter procedures associated with 
 the Company’s securities offerings.                                                                                            |

Our policy is to pre-approve all audit and permissible non-audit services
performed by the independent accountants. These services